Reason for request
Renouvellement d'inscription
Clinical Benefit
| Substantial |
La Commission considère que le service médical rendu par CHIBROXINE, 0,3 % reste important dans les indications de l'AMM.
|
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
RQKbeHuv0V03dhf2
